Bio
Angela Zhou is an Information Scientist at CAS. She earned her Ph.D. in Molecular Pharmacology and toxicology from University of Southern California. She was further trained as a cell biologist at Johns Hopkins School of Medicine and worked in the area of cancer biology at Harvard Medical School. She was a faculty member at Missouri State University and Denison University prior to joining CAS.
Emerging Science
是友非敌:肠道微生物组利于改善健康
肠道微生物组是一个由数万亿细菌组成的复杂生态系统,这些细菌存活在我们的消化道中,具有提供免疫力、改善心理健康和提供治疗选择等健康益处。 近年来,人们对微生物组疗法治疗各种疾病的潜力越来越感兴趣。 随着我们对肠道微生物组的理解不断加深,我们有望在未来几年看到微生物组疗法的更多进展。
Read the CAS Insights articleDrug Discovery
ACE2:靶向疾病发病机制中的潜在重要受体
了解更多 ACE2 相关信息,该重要蛋白仍是 COVID-19 和许多其他病毒感染的关键靶点。 本文概述了有关靶向 ACE2 蛋白的出版物、里程碑意义事件和未来应用的新兴趋势和洞察。
Read the CAS Insights articleEmerging Science
抑郁症和创伤后应激障碍(PTSD)的新希望
最近的临床试验结果表明,娱乐性迷幻药,如LSD、MDMA,以及裸盖菇素,在适当控制剂量和给药时有积极的治疗效果。 阅览最新研究。
Read the CAS Insights article